Invitae Corp
Change company Symbol lookup
Select an option...
NVTA Invitae Corp
LII Lennox International Inc
XPEV Xpeng Inc
SCHW-J Charles Schwab Corp
BIOT Biotech Acquisition Co
MICR Micron Solutions Inc
WSBF Waterstone Financial Inc
MBRX Moleculin Biotech Inc
STRNY Severn Trent PLC
BRSP Brightspire Capital Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other partners, thereby capturing the potential of genetics and helping to expand its use across the healthcare continuum. It offers Invitae Digital Health, a connected digital health platform that informs health decisions through actionable genomic insights for patients and clinicians. The Company offers genetic testing across multiple clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, personalized oncology, metabolic conditions, and rare diseases.

Closing Price
$2.46
Day's Change
0.07 (2.93%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.58
Day's Low
2.34
Volume
(Below Average)
Volume:
8,690,296

10-day average volume:
10,271,176
8,690,296
  • Prev Close
    2.39
  • Today's Open
    2.36
  • Day's Range
    2.34-2.58
  • Avg Vol (10-day)
    10.3M
  • Last (time)
    7:00p ET 09/30/22
  • Last (size)
    15
  • 52-Wk Range
    1.83 - 29.15
    LowHigh
  • (10/21/21 - 07/28/22)
    34.43%
  • 183.2%
  • Market Cap
    578.8M
  • Shares Outstanding
    235.3M
  • -13.48
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.6
  • 76.61
  • (% of float 09/15/22)
    16.75

Latest News

September 27, 2022
7:30 am ET
PR Newswire
September 22, 2022
11:00 am ET
PR Newswire
September 20, 2022
8:30 am ET
Globe Newswire
7:30 am ET
PR Newswire
September 15, 2022
4:00 pm ET
PR Newswire
September 12, 2022
7:30 am ET
PR Newswire
August 30, 2022
4:05 pm ET
PR Newswire
August 15, 2022
10:55 am ET
PR Newswire
August 12, 2022
11:36 am ET
PR Newswire
August 11, 2022
11:25 am ET
PR Newswire
7:11 am ET
MarketWatch
August 09, 2022
4:05 pm ET
PR Newswire
August 08, 2022
11:45 am ET
PR Newswire
August 02, 2022
7:00 am ET
PR Newswire
July 21, 2022
8:41 am ET
MarketWatch
July 19, 2022
6:06 am ET
MarketWatch
July 18, 2022
4:13 pm ET
PR Newswire
4:05 pm ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.